Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Feb;37(2):159–170. doi: 10.1038/bjc.1978.24

In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.

R C Burton, N L Warner
PMCID: PMC2009573  PMID: 75739

Abstract

Two 3-methylcholanthrene and a spontaneous BALB/c fibrosarcoma were examined for tumour-associated antigens (TAA) by in vivo and in vitro induction of tumour-immune responses. When BALB/c mice were immunized to these fibrosarcomas by surgical tumour removal, cross-reacting tumour-associated transplantation antigens (TATA) were detected on all 3 tumours. Cytotoxic effector cells (CL) were then induced in vitro by co-culture of BALB/c spleen cells with the spontaneous, or one of the carcinogen-induced fibrosarcomas. These CL were shown to be cytotoxic T cells (Tc) and to be directed against cross-reacting TAA on all 3 tumours, by two in vitro 51Cr-release assay systems, direct 51Cr-release cytotoxicity and cellular competitive inhibition of 51Cr release. Further studies demonstrated that the fibrosarcoma TAA involved in in vitro induction of Tc were not present on normal adult or foetal tissues. A secondary cytotoxic response was also detected in vitro when spleen cells from mice immunized to a carcinogen-induced fibrosarcoma were tested. The patterns of cross-reactivity detected by the in vivo and primary in vitro tumour-immune responses suggested that the TAA detected in vivo (TATA) were not identical to the TAA detected in vitro.

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W. Immunological aspects of chemical carcinogenesis. Adv Cancer Res. 1973;18:1–75. doi: 10.1016/s0065-230x(08)60750-2. [DOI] [PubMed] [Google Scholar]
  2. Bataillon G., Pross H., Klein G. Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicity. Int J Cancer. 1975 Aug 15;16(2):255–265. doi: 10.1002/ijc.2910160208. [DOI] [PubMed] [Google Scholar]
  3. Burdick J. F., Wells S. A., Jr Cross-reactivity between cell-surface antigens of different murine carcinogen-induced tumors, demonstrated by a modified isotopic antiglobulin test. J Natl Cancer Inst. 1973 Oct;51(4):1149–1156. doi: 10.1093/jnci/51.4.1149. [DOI] [PubMed] [Google Scholar]
  4. Burton R. C., Chism S. E., Warner N. L. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens. J Immunol. 1977 Mar;118(3):971–980. [PubMed] [Google Scholar]
  5. Burton R. C., Warner N. L. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses. J Natl Cancer Inst. 1977 Mar;58(3):701–709. doi: 10.1093/jnci/58.3.701. [DOI] [PubMed] [Google Scholar]
  6. Burton R., Thompson J., Warner N. L. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes. J Immunol Methods. 1975;8(1-2):133–149. doi: 10.1016/0022-1759(75)90090-3. [DOI] [PubMed] [Google Scholar]
  7. Chism S. E., Burton R. C., Grail D. L., Bell P. M., Warner N. L. In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique. J Immunol Methods. 1977;16(3):245–262. doi: 10.1016/0022-1759(77)90202-2. [DOI] [PubMed] [Google Scholar]
  8. Chism S. E., Burton R. C., Warner N. L. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens. J Natl Cancer Inst. 1976 Aug;57(2):377–387. doi: 10.1093/jnci/57.2.377. [DOI] [PubMed] [Google Scholar]
  9. Cohen I. R., Globerson A., Feldman M. Autosensitization in vitro. J Exp Med. 1971 Apr 1;133(4):834–845. doi: 10.1084/jem.133.4.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frbes J. T., Nakaw Y., Smith R. T. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens. J Exp Med. 1975 May 1;141(5):1181–1200. doi: 10.1084/jem.141.5.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fritze D., Kern D. H., Humme J. A., Drogemuller C. R., Pilch Y. H. Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogens. Int J Cancer. 1976 Jan 15;17(1):138–147. doi: 10.1002/ijc.2910170118. [DOI] [PubMed] [Google Scholar]
  12. Harder F. H., McKhann C. F. Demonstration of cellular antigens on sarcoma cells by an indirect 125-I-labeled antibody technique. J Natl Cancer Inst. 1968 Feb;40(2):231–241. [PubMed] [Google Scholar]
  13. Hellström I., Hellström K. E., Pierce G. E. In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Int J Cancer. 1968 Jul 15;3(4):467–482. doi: 10.1002/ijc.2910030408. [DOI] [PubMed] [Google Scholar]
  14. Hewitt H. B., Blake E. R., Walder A. S. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer. 1976 Mar;33(3):241–259. doi: 10.1038/bjc.1976.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ilfeld D., Carnaud C., Cohen I. R., Trainin N. In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro. Int J Cancer. 1973 Jul 15;12(1):213–222. doi: 10.1002/ijc.2910120122. [DOI] [PubMed] [Google Scholar]
  16. KLEIN G., SJOGREN H. O., KLEIN E., HELLSTROM K. E. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 1960 Dec;20:1561–1572. [PubMed] [Google Scholar]
  17. Kall M. A., Hellström I., Hellström K. E. In vitro generation of primary and secondary cytotoxic cell-mediated immune responses to chemically induced mouse sarcomas. Int J Cancer. 1976 Oct 15;18(4):488–497. doi: 10.1002/ijc.2910180414. [DOI] [PubMed] [Google Scholar]
  18. Kall M. A., Hellström I. Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens. J Immunol. 1975 Mar;114(3):1083–1088. [PubMed] [Google Scholar]
  19. Kearney R., Basten A., Nelson D. S. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer. 1975 Mar 15;15(3):438–450. doi: 10.1002/ijc.2910150310. [DOI] [PubMed] [Google Scholar]
  20. McKhann C. F., Jagarlamoody S. M. Evidence for immune reactivity against neoplasms. Transplant Rev. 1971;7:55–77. doi: 10.1111/j.1600-065x.1971.tb00463.x. [DOI] [PubMed] [Google Scholar]
  21. Oth F. R., Dumont F. Cross-immunity between chemically-induced sarcomas, detected by transplantation in restricted genetic conditions. Eur J Cancer. 1973 Nov-Dec;9(11-12):877–878. doi: 10.1016/0014-2964(73)90031-5. [DOI] [PubMed] [Google Scholar]
  22. Prehn R. T. Relationship of tumor immunogenicity to concentration of the oncogen. J Natl Cancer Inst. 1975 Jul;55(1):189–190. doi: 10.1093/jnci/55.1.189. [DOI] [PubMed] [Google Scholar]
  23. Reiner J., Southam C. M. Evidence of common antigenic properties in chemically induced sarcomas of mice. Cancer Res. 1967 Jul;27(7):1243–1247. [PubMed] [Google Scholar]
  24. Röllinghoff M., Rouse B. T., Warner N. L. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors. J Natl Cancer Inst. 1973 Jan;50(1):159–172. doi: 10.1093/jnci/50.1.159. [DOI] [PubMed] [Google Scholar]
  25. Röllinghoff M. Secondary cytotoxic tumor immune response induced in vitro. J Immunol. 1974 May;112(5):1718–1725. [PubMed] [Google Scholar]
  26. Röllinghoff M., Wagner H. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo. Eur J Immunol. 1973 Aug;3(8):471–476. doi: 10.1002/eji.1830030804. [DOI] [PubMed] [Google Scholar]
  27. Röllinghoff M., Warner N. L. Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc Soc Exp Biol Med. 1973 Dec;144(3):813–818. doi: 10.3181/00379727-144-37688. [DOI] [PubMed] [Google Scholar]
  28. Sanderson C. J. The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse microcinematography. Proc R Soc Lond B Biol Sci. 1976 Jan 20;192(1107):241–255. doi: 10.1098/rspb.1976.0011. [DOI] [PubMed] [Google Scholar]
  29. Small M., Trainin N. Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor. Int J Cancer. 1975 Jun 15;15(6):962–972. doi: 10.1002/ijc.2910150612. [DOI] [PubMed] [Google Scholar]
  30. Takasugi M., Klein E. A microassay for cell-mediated immunity. Transplantation. 1970 Mar;9(3):219–227. doi: 10.1097/00007890-197003000-00005. [DOI] [PubMed] [Google Scholar]
  31. WINN H. J. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol. 1961 Feb;86:228–239. [PubMed] [Google Scholar]
  32. Wahl D. V., Chapman W. H., Hellström I., Hellström K. E. Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice. Int J Cancer. 1974 Jul 15;14(1):114–121. doi: 10.1002/ijc.2910140114. [DOI] [PubMed] [Google Scholar]
  33. Warnatz H., Scheiffarth F. Cell-mediated immune response of in vitro sensitized lymphocytes to isogeneic methyl-cholanthrene-induced tumor cell lines. Transplantation. 1974 Sep;18(3):273–279. doi: 10.1097/00007890-197409000-00011. [DOI] [PubMed] [Google Scholar]
  34. Whitney R. B., Levy J. G., Smith A. G. Studies on the effector cell of anti-tumour immunity in a chemically induced mouse tumour system. Br J Cancer. 1975 Feb;31(2):157–163. doi: 10.1038/bjc.1975.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. von Boehmer H., Shortman K. The separation of different cell classes from lymphoid organs. IX. A simple and rapid method for removal of damaged cells from lymphoid cell suspensions. J Immunol Methods. 1973 Apr;2(3):293–301. doi: 10.1016/0022-1759(73)90055-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES